Investment Philosophy

ABG invests in healthcare globally through its “3-by-3” strategy in 3 key geographies: 1) China, where ABG’s roots are; 2) the US; and 3) Europe; through 3 products/vehicles: 1) innovation (late-stage venture and early growth capital); 2) buyout and larger growth capital; and 3) hedge fund. ABG has proven its success in each of the 3-by-3 categories. All of these investment strategies/vehicles leverage the same industry expertise, network, deal-making and value-add capabilities – all on a global basis – of the ABG Team. ABG primarily focuses on biopharmaceuticals, medical devices and healthcare IT with a successful investment portfolio in China, the US and Europe across various stages, that contains some of the world’s most innovative life science technologies.